SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-21-093551
Filing Date
2021-07-19
Accepted
2021-07-19 17:27:09
Documents
8
Effectiveness Date
2021-07-19

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2122419d1_s-8.htm S-8 84071
2 EXHIBIT 5.1 tm2122419d1_ex5-1.htm EX-5.1 12550
3 EXHIBIT 23.1 tm2122419d1_ex23-1.htm EX-23.1 2109
4 EXHIBIT 99.2 tm2122419d1_ex99-2.htm EX-99.2 69416
5 EXHIBIT 99.3 tm2122419d1_ex99-3.htm EX-99.3 76449
6 EXHIBIT 99.4 tm2122419d1_ex99-4.htm EX-99.4 86012
7 GRAPHIC image_001.jpg GRAPHIC 2277
8 GRAPHIC image_002.jpg GRAPHIC 8006
  Complete submission text file 0001104659-21-093551.txt   346111
Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Filer) CIK: 0001736243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-258026 | Film No.: 211098742
SIC: 2834 Pharmaceutical Preparations